Sign in

NCT07873931Not yet recruitingPhase 1

A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases

A Phase 1, Multicenter, Open-Label Study of BMS-986553, CD19 In Vivo Chimeric Antigen Receptor (CAR) T Cells, in Participants With Refractory Autoimmune Diseases

Source: ClinicalTrials.gov · Last updated 14 Oct 2026

Brief summary (registry, in English)

The purpose of this study is to evaluate the safety and tolerability of BMS-986553, CD19 in vivo Chimeric Antigen Receptor (CAR) T cells, in participants with refractory autoimmune diseases including systemic lupus erythematosus (SLE), idiopathic inflammatory myopathies (IIM), systemic sclerosis (SSc), rheumatoid arthritis (RA), and Sjögren's disease (SjD).

Status (registry)
Not yet recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
60 (estimated)
First submitted
8 Oct 2026
Start date
30 Oct 2026
Primary completion date
20 Oct 2032
Lead sponsor
Bristol-Myers Squibb
NCT number
NCT07873931
EudraCT number
2026-525936-41

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 60
  • From 30 Oct 2026 to the primary completion date, 20 Oct 2032
  • 23 sites in 6 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Participants must not have other systemic immune disorders. Other protocol-defined Inclusion/Exclusion criteria apply.

Who the study is looking for

  • SLE participants: Must have diagnosis of SLE defined as fulfilling the 2019 ACR/EULAR classification criteria of SLE.
  • IIM participants: Must have diagnosis of IIM defined as fulfilling the 2017 ACR/EULAR classification criteria for probable or definite IIM.
  • SSc participants: Must have diagnosis of SSc defined as fulfilling 2013 ACR/EULAR classification criteria for SSc.
  • RA participants: Must have diagnosis of RA, defined as fulfilling 2010 ACR/EULAR criteria for RA.
  • Primary SjD Participants: Must have diagnosis fulfilling the 2016 ACR/EULAR Classification Criteria.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (23)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Local Institution - 0029
Coordinator of this site? Confirm its status
LeuvenBelgiumUnknown status
Local Institution - 0028
Coordinator of this site? Confirm its status
BerlinGermanyUnknown status
Local Institution - 0060
Coordinator of this site? Confirm its status
ErlangenGermanyUnknown status
Local Institution - 0059
Coordinator of this site? Confirm its status
MagdeburgGermanyUnknown status
Local Institution - 0027
Coordinator of this site? Confirm its status
WürzburgGermanyUnknown status
Local Institution - 0039
Coordinator of this site? Confirm its status
MontpellierFranceUnknown status
Local Institution - 0047
Coordinator of this site? Confirm its status
ParisFranceUnknown status
Local Institution - 0055
Coordinator of this site? Confirm its status
AmsterdamNetherlandsUnknown status
Local Institution - 0063
Coordinator of this site? Confirm its status
LeidenNetherlandsUnknown status
Local Institution - 0051
Coordinator of this site? Confirm its status
BydgoszczPolandUnknown status
Local Institution - 0050
Coordinator of this site? Confirm its status
KrakowPolandUnknown status
Local Institution - 0046
Coordinator of this site? Confirm its status
PoznanPolandUnknown status
Local Institution - 0004
Coordinator of this site? Confirm its status
Ann ArborUnited StatesUnknown status
Local Institution - 0052
Coordinator of this site? Confirm its status
Great NeckUnited StatesUnknown status
Local Institution - 0007
Coordinator of this site? Confirm its status
MorristownUnited StatesUnknown status
Local Institution - 0064
Coordinator of this site? Confirm its status
Newport BeachUnited StatesUnknown status
Local Institution - 0062
Coordinator of this site? Confirm its status
OmahaUnited StatesUnknown status
Local Institution - 0008
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
Local Institution - 0013
Coordinator of this site? Confirm its status
Saint PaulUnited StatesUnknown status
Local Institution - 0015
Coordinator of this site? Confirm its status
Salt Lake CityUnited StatesUnknown status
Local Institution - 0005
Coordinator of this site? Confirm its status
SeattleUnited StatesUnknown status
Local Institution - 0003
Coordinator of this site? Confirm its status
SeattleUnited StatesUnknown status
Local Institution - 0001
Coordinator of this site? Confirm its status
WorcesterUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.